PODD
Insulet Corporation
NASDAQ · Healthcare · Medical - Devices · US
$147.48
−2.06%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
21.4x
EV/EBITDA
16.7x
Market Cap
$10.23B
MomentumView details →
1D Return
−2.06%
YTD Return
−48.10%
RSI (14)
47.9
ValuationView details →
P/E (Fwd)
21.4x
EV/EBITDA
16.7x
Market Cap
$10.23B
RSI (14)
47.9
MomentumView details →
1D Return
−2.06%
YTD Return
−48.10%
SummaryUpdated Jun 1, 2026
Insulet Corporation (NASDAQ:PODD) is a medical device company founded in 2000 and headquartered in Acton, Massachusetts. The company went public in 2007 and has established itself as a leading innovator in diabetes care technology. Insulet specializes in developing, manufacturing, and selling tubeless insulin delivery systems for people with insulin-dependent diabetes. The company has grown from a startup focused on revolutionizing insulin pump technology to a global leader serving over 500,000 customers worldwide, with nine consecutive years of 20%+ revenue growth through 2024.
Similar companies
Latest newsMore news →
Algert Global LLC increased its stake in Insulet Corporation by 75.7% during the second quarter, acquiring 62,277 additional shares, as disclosed in a 13F filing.11d agoAurora Investment Counsel purchased a new stake of 14,672 shares in Insulet Corporation, valued at approximately $2,234,000, as disclosed in a 13F filing.16d agoA securities class action lawsuit was filed against Insulet Corporation alleging it misled investors about the safety and reliability of its insulin delivery products.22d ago